Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03WPP
|
|||
| Former ID |
DNCL002787
|
|||
| Drug Name |
Necitumumab
|
|||
| Synonyms |
LY3012211
Click to Show/Hide
|
|||
| Drug Type |
Monoclonal antibody
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Approved | [1], [2] | |
| Company |
Lilly
|
|||
| ADReCS Drug ID | BADD_D01543 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8090). | |||
| REF 2 | ClinicalTrials.gov (NCT00981058) First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin. U.S. National Institutes of Health. | |||
| REF 3 | Rindopepimut, a 14-mer injectable peptide vaccine against EGFRvIII for the potential treatment of glioblastoma multiforme. Curr Opin Mol Ther. 2010 Dec;12(6):741-54. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.